Moreover, IGF2BP2-stabilized hexokinase 2 (HK2) and IGF2BP2/3-stabilized solute carrier family 2 member 1 (SLC2A1, GLUT1) activate glycolysis to promote CRC progression 67. This evidence concerns the gene SLC2A1 and colorectal carcinoma.